Literature DB >> 18936640

Medical management of glaucoma.

Casey C Geringer1, Nauman R Imami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18936640     DOI： 10.1097/IIO.0b013e318187e8b5

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  6 in total

1.  Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma.

Authors:  Mohammad Pakravan; Afsaneh Naderi Beni; Shahin Yazdani; Hamed Esfandiari; Shahram Mirshojaee
Journal:  J Drug Assess       Date:  2021-08-23

Review 2.  Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 3.  Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.

Authors:  Monique P Curran; Jennifer S Orman
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Brinzolamide/timolol: in open-angle glaucoma and ocular hypertension.

Authors:  Jamie D Croxtall; Lesley J Scott
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.

Authors:  Kaidi Wang; Li Xu; Zhilan Yuan; Ke Yao; Junmei Zhao; Liang Xu; Aiwu Fang; Mingzhi Zhang; Lingling Wu; Jian Ji; Jiamin Hou; Qing Liu; Xinghuai Sun
Journal:  BMC Ophthalmol       Date:  2014-02-25       Impact factor: 2.209

6.  Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China.

Authors:  Xinghuai Sun; Qinghuai Liu; Xin Tang; Ke Yao; Yan Li; Jin Yang; Mingchang Zhang; Huiping Yuan; Yan Zheng; Weining Li; Huacong Peng
Journal:  BMC Ophthalmol       Date:  2022-08-05       Impact factor: 2.086
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.